Next Article in Journal / Special Issue
Small Molecule Inhibitors of Bcl-2 Family Proteins for Pancreatic Cancer Therapy
Previous Article in Journal
To Die or to Survive, a Fatal Question for the Destiny of Prostate Cancer Cells after Androgen Deprivation Therapy
Previous Article in Special Issue
Current State of Surgical Management of Pancreatic Cancer
Article Menu

Export Article

Open AccessReview
Cancers 2011, 3(2), 1513-1526; doi:10.3390/cancers3021513

Epidermal Growth Factor Receptor in Pancreatic Cancer

Hepatobiliary Surgery Unit, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK
Genetic Medicine, MAHSC, University of Manchester, St Mary’s Hospital, Oxford Road, Manchester, M13 9WL, UK
Author to whom correspondence should be addressed.
Received: 5 February 2011 / Revised: 28 February 2011 / Accepted: 11 March 2011 / Published: 24 March 2011
(This article belongs to the Special Issue Pancreatic Cancer)
View Full-Text   |   Download PDF [226 KB, uploaded 24 March 2011]   |  


Pancreatic cancer is the fourth leading cause of cancer related death. The difficulty in detecting pancreatic cancer at an early stage, aggressiveness and the lack of effective therapy all contribute to the high mortality. Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, which is expressed in normal human tissues. It is a member of the tyrosine kinase family of growth factors receptors and is encoded by proto-oncogenes. Several studies have demonstrated that EGFR is over-expressed in pancreatic cancer. Over-expression correlates with more advanced disease, poor survival and the presence of metastases. Therefore, inhibition of the EGFR signaling pathway is an attractive therapeutic target. Although several combinations of EGFR inhibitors with chemotherapy demonstrate inhibition of tumor-induced angiogenesis, tumor cell apoptosis and regression in xenograft models, these benefits remain to be confirmed. Multimodality treatment incorporating EGFR-inhibition is emerging as a novel strategy in the treatment of pancreatic cancer.
Keywords: EGFR; mutation; expression; pancreatic cancer EGFR; mutation; expression; pancreatic cancer

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Oliveira-Cunha, M.; Newman, W.G.; Siriwardena, A.K. Epidermal Growth Factor Receptor in Pancreatic Cancer. Cancers 2011, 3, 1513-1526.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top